Tela Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary

TELA Bio

10/05/2022 22:45

* TELA Bio Inc  TELA.OQ  reported a quarterly adjusted loss
of 75
cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 56 cents per share.
    * Revenue rose 40.1% to $8.23 million from a year ago; 
analysts
expected $7.95 million. 
    * TELA Bio Inc's reported EPS for the quarter was a loss
of 75
cents​.
    * The mean earnings estimate of analysts had fallen by
about 18.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * TELA Bio Inc shares had fallen by 21.6% this quarter and
lost 28.8% so far this year.
    * The company reported a quarterly loss of $10.86 million.
    * Wall Street's median 12-month price target for TELA Bio
Inc is
$20.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 09:44 p.m.  ​All
figures in US dollars unless otherwise stated